Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB13066 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB13066, RRID:AB_10552594
- Product name
- CRADD polyclonal antibody
- Antibody type
- Polyclonal
- Description
- Rabbit polyclonal antibody raised against synthetic peptide of CRADD.
- Storage
- Store at 4°C for three months. For long term storage store at -20°C.Aliquot to avoid repeated freezing and thawing.
Submitted references The CARD domain: a new apoptotic signalling motif.
RAIDD is a new 'death' adaptor molecule.
CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.
Hofmann K, Bucher P, Tschopp J
Trends in biochemical sciences 1997 May;22(5):155-6
Trends in biochemical sciences 1997 May;22(5):155-6
RAIDD is a new 'death' adaptor molecule.
Duan H, Dixit VM
Nature 1997 Jan 2;385(6611):86-9
Nature 1997 Jan 2;385(6611):86-9
CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.
Ahmad M, Srinivasula SM, Wang L, Talanian RV, Litwack G, Fernandes-Alnemri T, Alnemri ES
Cancer research 1997 Feb 15;57(4):615-9
Cancer research 1997 Feb 15;57(4):615-9
No comments: Submit comment
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Western blot analysis of CRADD in whole cell lysates from HeLa (H) or K-562 (K) cells with CRADD polyclonal antibody (Cat # PAB13066) at 1 : 500 dilution.
Supportive validation
- Submitted by
- Abnova Corporation (provider)
- Main image
- Experimental details
- Immunocytochemistry of CRADD in HeLa cells with CRADD polyclonal antibody (Cat # PAB13066) at 5 ug/mL .
- Validation comment
- Immunocytochemistry